A. Srinivasan

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

Dik J. Kwekkeboom, Willem H. Bakker, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 418 citations · Full text

Surgical Oncology, Pancreatic Cancer, Medicine +6

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

M. de Jong, W A Breeman, WH Bakker et al. · PubMed · 1998 · 210 citations

Engineering, Chemoprevention Strategy, In-labeled Somatostatin +21

Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy

P. Martin van Hagen, Wout A. P. Breeman, H.F. Bernard et al. · International Journal of Cancer · 2000 · 137 citations · Full text

Oncologic Imaging, Imaging Agent, Tumor Biology +22

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

Jason S. Lewis, Michael R. Lewis, Paul Cutler et al. · PubMed · 1999 · 110 citations

Ca20948 Tumor-bearing Rats, Engineering, Pathology +17

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

M. Visser, Paul J. J. M. Janssen, A. Srinivasan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 100 citations

Neuro-oncology, Pancreatic Cancer, 111In-labelled Dtpa- +8